Deals and Moves: Dec. 27

Medical technology company BD, in Franklin Lakes, announced Wednesday the completion of its acquisition of Safety Syringes Inc., of California. Terms were not disclosed.

Central

NovaDel Pharma Inc., of Bridgewater, on Wednesday announced a preliminary agreement to sell its NovaMist technology to SUDA LTD, an Australian pharmaceutical company. Terms were not disclosed.

Princeton-based Soligenix Inc., a development stage biopharmaceutical company, today announced it has regained the North American and European commercial rights to its oral BDP treatment through an amendment of an agreement with Sigma-Tau Pharmaceuticals Inc.